VC-Backed Medicago Gets Loan Extension
Medicago Inc., a clinical-stage biopharmaceuticals company focused on developing novel vaccines and therapeutic proteins to address a broad range of infectious diseases, has received an extension of its C$15.3 million loan to 2017 from government-owned Investissement Québec. The publicly-listed, Québec City-based Medicago has been backed by several Canadian VC firms since the late 1990s. Company investors have included the Fonds de solidarité des travailleurs du Québec (FTQ).
8 February 2013•4 mins read
